Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» dupilumab
dupilumab
Is There Pipeline Potential in These 3 Biotech Stocks?
Motley Fool
Thu, 08/8/13 - 09:02 am
Regeneron
REGN-727
dupilumab
Abexinostat
Pharmacyclics
AVI-7288
Sarepta Therapeutics
Regeneron's New Asthma Drug And Its Fierce Competitors
Seeking Alpha
Thu, 06/27/13 - 12:53 am
Regeneron
asthma
Teva
GSK
Sanofi
dupilumab
The First Real Cure in the $25 billion Asthma Market?
Motley Fool
Wed, 06/12/13 - 12:35 pm
asthma
dupilumab
Sanofi
Regeneron
Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial
Seeking Alpha
Tue, 05/28/13 - 09:30 am
asthma
Sanofi
Regeneron
dupilumab
New Asthma Drug Generates Excitement For Patients -- And Its Maker
Forbes
Tue, 05/21/13 - 10:13 am
asthma
Regeneron
dupilumab
Pages
« first
‹ previous
1
2